Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Electronic Health Record Standards Add UDI For Implantable Devices

This article was originally published in SRA

Executive Summary

New certification requirements for a US federal program that provides a financial incentive to healthcare facilities that use electronic health records (EHRs) require that the EHR software used by participating facilities incorporates unique device identifiers (UDIs) for implantable devices.

You may also be interested in...



UDIs Should Be Added To Insurance Claims, Panel Agrees

The X12 committee, a panel that helps sets standards for insurance documentation in the US, has agreed that Unique Device Identifiers should be added to Medicare and private-payer claims forms, a move that some groups say could make it easier to track long-term safety and performance of implants. But device companies oppose the move.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040632

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel